MS vs CME stock comparison
Morgan Stanley vs. CME Group · data as of November 13, 2026
Morgan Stanley (MS) has a market value of about $298.4B, CME Group (CME) about $113.8B. Over their latest twelve months Morgan Stanley had revenue of $80.2B and CME Group $7.0B.
On our five checks CME Group scores higher: 2.4 out of 5 (weak) against 1.8 (weak).
By area, the stronger company is Morgan Stanley on value; CME Group on financial health.
Morgan Stanley is cheaper on earnings (P/E 15.1 vs. 26.1).
Morgan Stanley leads on 13 of the compared lines and CME Group on 6.
Side by side
| MS | CME | |
|---|---|---|
| Size and price | ||
| Market cap | $298.4B | $113.8B |
| Share price | $190.65 | $317.97 |
| Score | ||
| Overall score (of 5) | 1.8 | 2.4 |
| Value | 1 | 0 |
| Future growth | 2 | 2 |
| Track record | 2 | 2 |
| Financial health | 0 | 4 |
| Shareholder returns | 4 | 4 |
| Valuation | ||
| P/E (TTM) | 15.1 | 26.1 |
| Forward P/E | 14.3 | 24.5 |
| Price / free cash flow | — | 26.3 |
| Price / sales | 3.7 | 16.3 |
| EV / EBITDA | 17.8 | 24.6 |
| PEG | 1.58 | 1.90 |
| DCF value vs. price | −1% | −41% |
| Business | ||
| Revenue | $80.2B | $7.0B |
| Net income | $19.8B | $4.4B |
| Free cash flow | -$61.5B | $4.3B |
| Net margin | 24.8% | 63.3% |
| Gross margin (5-yr avg.) | — | — |
| ROIC (5-yr avg.) | — | 8.7% |
| Growth | ||
| Revenue growth (1 yr) | 14.4% | 6.4% |
| Revenue growth (5 yrs, per year) | 7.7% | 5.9% |
| EPS growth (5 yrs, per year) | 9.6% | 13.7% |
| Balance sheet and payouts | ||
| Net cash (cash minus debt) | -$249.9B | -$1.5B |
| Dividend yield | 2.41% | 1.64% |
| Shareholder yield | 2.4% | 1.6% |
| Analysts | ||
| Upside to average target | +11% | −0% |
| Consensus rating | Buy | Buy |
Highlighted = the better figure on that line. Revenue, net income and free cash flow: MS TTM to September 30, 2026, CME TTM to September 30, 2026. Not investment advice.
Frequently asked questions
Which is the better stock, Morgan Stanley or CME Group?
We do not give buy or sell advice. On our five checks (value, growth, track record, financial health and shareholder returns) CME Group scores 2.4 out of 5 and Morgan Stanley 1.8; the table shows where each one is stronger.
Is Morgan Stanley cheaper than CME Group?
On trailing earnings, Morgan Stanley trades at a P/E of 15.1 and CME Group at 26.1, so Morgan Stanley is cheaper by this measure. A lower P/E can also reflect slower expected growth.
Which grows faster, Morgan Stanley or CME Group?
Over five years Morgan Stanley grew revenue about 7.7% a year and CME Group about 5.9% a year.
Which pays a higher dividend?
Morgan Stanley yields 2.41% and CME Group 1.64%.
Full Morgan Stanley analysis → Full CME Group analysis →
More comparisons
Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.